Pharmacogenetics of angiotensin-converting enzyme inhibitor-induced angioedema

Pharmacogenomics. 2021 Apr;22(6):319-321. doi: 10.2217/pgs-2021-0036. Epub 2021 Apr 14.

Authors

Amalie Hartvig Pall¹, Eva Rye Rasmussen², Mia Wadelius³

Affiliations

¹ Department of Emergency, Nykoebing Falster Hospital, Region Zealand, Denmark, Denmark.
² ENT Private Clinic, Noerregade 3, 4600 Koege, Denmark, Denmark.
³ Department of Medical Sciences, Clinical Pharmacogenomics, Uppsala University, Uppsala, Sweden.

PMID: 33849279
DOI: 10.2217/pgs-2021-0036

No abstract available

Keywords: ACE inhibitor; angioedema; pharmacogenetics.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Angioedema / chemically induced*
Angioedema / genetics*
Angiotensin-Converting Enzyme Inhibitors / adverse effects*
Humans
Pharmacogenetics*

Substances

Angiotensin-Converting Enzyme Inhibitors